<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2461">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05129124</url>
  </required_header>
  <id_info>
    <org_study_id>21-012</org_study_id>
    <nct_id>NCT05129124</nct_id>
  </id_info>
  <brief_title>Insertion Clinical Study to Evaluate the Orientation Characteristics of Multiple Kalifilcon A Daily Disposable Toric LD213001 Contact Lenses</brief_title>
  <official_title>Insertion Clinical Study to Evaluate the Orientation Characteristics of Multiple Kalifilcon A Daily Disposable Toric LD213001 Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to evaluate the fit characteristics (primary gaze orientation, rotational&#xD;
      recovery, and movement) of kalifilcon A daily disposable toric lenses as compared to&#xD;
      commercially available Ultra for Astigmatism lenses.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 30, 2021</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Absolute Primary Gaze Orientation at 3 minutes for the lenses inserted at 90 degrees</measure>
    <time_frame>3 minutes</time_frame>
  </primary_outcome>
  <number_of_arms>14</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>T01: +6.00 -2.75 x 180</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>kalifilcon A Daily Disposable Toric LD213001 Contact Lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>T02: +6.00-2.75 x 090</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>kalifilcon A Daily Disposable Toric LD213001 Contact Lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>T03: -3.00-2.75 x180</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>kalifilcon A Daily Disposable Toric LD213001 Contact Lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>T04: -3.00 -2.75 x 090</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>kalifilcon A Daily Disposable Toric LD213001 Contact Lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>T05: -9.00 -2.75 x 180</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>kalifilcon A Daily Disposable Toric LD213001 Contact Lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>T06: -9.00 -2.75 x 090</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>kalifilcon A Daily Disposable Toric LD213001 Contact Lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>T07: -12.00 -2.75 x 180</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>kalifilcon A Daily Disposable Toric LD213001 Contact Lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>T08: -12.00-2.75 x 090</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>kalifilcon A Daily Disposable Toric LD213001 Contact Lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C01: +6.00 -2.75 x 180</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Commercially available Ultra for Astigmatism Contact Lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C02: +6.00-2.75 x 090</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Commercially available Ultra for Astigmatism Contact Lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C03: -3.00-2.75 x180</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Commercially available Ultra for Astigmatism Contact Lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C04: -3.00 -2.75 x 090</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Commercially available Ultra for Astigmatism Contact Lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C05: -9.00 -2.75 x 180</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Commercially available Ultra for Astigmatism Contact Lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C06: -9.00 -2.75 x 090</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Commercially available Ultra for Astigmatism Contact Lenses</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>kalifilcon A Daily Disposable Toric LD213001 Contact Lenses</intervention_name>
    <description>kalifilcon A Daily Disposable Toric LD213001 Contact Lenses at different fittings</description>
    <arm_group_label>T01: +6.00 -2.75 x 180</arm_group_label>
    <arm_group_label>T02: +6.00-2.75 x 090</arm_group_label>
    <arm_group_label>T03: -3.00-2.75 x180</arm_group_label>
    <arm_group_label>T04: -3.00 -2.75 x 090</arm_group_label>
    <arm_group_label>T05: -9.00 -2.75 x 180</arm_group_label>
    <arm_group_label>T06: -9.00 -2.75 x 090</arm_group_label>
    <arm_group_label>T07: -12.00 -2.75 x 180</arm_group_label>
    <arm_group_label>T08: -12.00-2.75 x 090</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Commercially available Ultra for Astigmatism Contact Lenses</intervention_name>
    <description>Commercially available Ultra for Astigmatism Contact Lenses at different fittings</description>
    <arm_group_label>C01: +6.00 -2.75 x 180</arm_group_label>
    <arm_group_label>C02: +6.00-2.75 x 090</arm_group_label>
    <arm_group_label>C03: -3.00-2.75 x180</arm_group_label>
    <arm_group_label>C04: -3.00 -2.75 x 090</arm_group_label>
    <arm_group_label>C05: -9.00 -2.75 x 180</arm_group_label>
    <arm_group_label>C06: -9.00 -2.75 x 090</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Be 18 years or older on the date the Informed Consent Form (ICF) is signed and have&#xD;
             capacity to read, understand and provide written voluntary informed consent.&#xD;
&#xD;
          2. Have physiologically normal anterior segments not exhibiting clinically significant&#xD;
             biomicroscopy findings.&#xD;
&#xD;
          3. Have no active ocular disease or allergic conjunctivitis.&#xD;
&#xD;
          4. Not be using any topical ocular medications.&#xD;
&#xD;
          5. Be willing and able to follow instructions.&#xD;
&#xD;
          6. Have signed a statement of informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Participating in a conflicting study.&#xD;
&#xD;
          2. Considered by the Investigator to not be a suitable candidate for participation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffery Schafer, OD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bausch &amp; Lomb Incorporated</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robert Steffen</last_name>
    <phone>15853386399</phone>
    <email>robert.steffen@bausch.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bausch and Lomb Site 01</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14609</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bausch and Lomb S 01</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>November 10, 2021</study_first_submitted>
  <study_first_submitted_qc>November 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 22, 2021</study_first_posted>
  <last_update_submitted>December 14, 2021</last_update_submitted>
  <last_update_submitted_qc>December 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

